Chime Biologics

About:

Chime Biologics is a biopharmaceutical development and manufacturing company.

Website: https://chimebiologics.com/#

Top Investors: Fidelity International, BioVenture, Panacea Venture, VMS Asset Management, Panacea Venture

Description:

Chime Biologics, is a world-class experienced Contract Development and Manufacturing Organization (CDMO), providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing. We provide a comprehensive solution supporting our customers from analytical and process transfer to early-stage biopharmaceutical development through late-stage clinical and commercial drug substance and drug product manufacturing for Global Supply.

Total Funding Amount:

$332M

Headquarters Location:

Wuhan, Hubei, China

Founded Date:

2013-01-01

Contact Email:

bd(AT)chimebiologics.com

Founders:

Andrew Ng, John Zeng

Number of Employees:

251-500

Last Funding Date:

2023-02-01

IPO Status:

Private

© 2025 bioDAO.ai